76.300USD+76.300盘后交易 06/26, 20:00 (美东)
关键数据
76.640今开
77.590最高
15.72M成交量
12.59市盈率 TTM
10.64市盈率动
2.060股息TTM
3.70%换手率
77.820昨收
75.550最低
504.49M成交额
13.00市盈率静
9.70市净率
2.71%股息率 TTM
18.07%ROA
172.23052周最高
1.95量比
2.49B净利润
424.93M总股本
6.0419每股收益TTM
0.77Beta
67.01%ROE
72.38052周最低
2.62%振幅
70.29%毛利率
32.32B总市值
-0.36回报/风险
1.59%风险率
操作建议
硕腾当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在药品行业排名35/157位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价124.08。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。
压力支撑

由于公司未披露,未能获取相关数据
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议
财务指标
每股收益

由于公司未披露,未能获取相关数据
营业总收入

由于公司未披露,未能获取相关数据
硕腾简介
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
公司代码ZTS
公司硕腾
CEOPeck (Kristin C)
网址https://www.zoetis.com/
常见问题
根据分析师评级,硕腾(ZTS)的总体评级为买入,目标价格为123.41。
硕腾(ZTS)股票的每股收益(EPS TTM)是多少
硕腾(ZTS)股票的每股收益(EPS TTM)是6.03。